Category: Elekta AB
Shares of Elekta slide after the Swedish medtech maker reports lower profits for the 1st half of fiscal 2014.
Elekta (STO:EKTA B) shares are down today after the Swedish medtech maker reported lower profits for its fiscal 2014 1st half.
Elekta appoints former Nokia markets VP Niklas Savander as its new CEO and president.
Elekta (STO:EKTA B) said it named Niklas Savander, a former Nokia executive, as its new president & CEO. Savander is succeeding Tomas Puusepp, who will keep his seat on Stockholm-based company's board.
IT's Savander's 1st venture into the medical device industry. His resume includes stints at Hewlett-Packard as well as Nokia, according to a press release.
Cancer-treatment devices maker Elekta's $25 million Chinese order is its largest to date.
Rival radiological device makers Elekta and Varian Medical settle a lawsuit accusing the Swedish company of poaching sales reps and trade secrets from Varian.
A new reimbursement proposal from the Center for Medicare & Medicaid Services would level payments for brain tumor radiosurgery performed with technology from either Swedish Elekta and California-based Varian.
Elekta's next-generation Versa HD linear accelerator aims to provide faster and more efficient tumor targeting.
Atlanta medical device company Elekta (STO:EKTA B) this week announced FDA clearance for its Versa HD linear accelerator, allowing the company to move forward with shipping and installations.
McKesson agrees to pony up more than $2 billion for medical supplies provider PSS World Medical.
McKesson (NYSE:MCK) agreed to pay $29 per share for PSS World Medical (NSDQ:PSSI) and its medical supplies business in a deal worth $2.1 billion.